(Post-pandemic Era)-Global Bioresorbable Medical Polymer Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027

Report Code : XYZ2438576
Published On: Apr, 2021
Category : Medical Devices
Pages : 104

As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Research published a report for global Bioresorbable Medical Polymer market in this environment.

In terms of revenue, this research report indicated that the global Bioresorbable Medical Polymer market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Bioresorbable Medical Polymer industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

The Evonik aims at producing XX K Units Bioresorbable Medical Polymer in 2020, with XX % production to take place in global market, Corbion accounts for a volume share of XX %.

Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Bioresorbable Medical Polymer Market Include by
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Bioresorbable Medical Polymer Market
Evonik
Corbion
DSM
Mitsui Chemicals
PCAS
Poly-Med
KLS Martin

Major Type of Bioresorbable Medical Polymer Covered in Research report:
Polylactic Acid (PLA)
Polyglycolic Acid (PGA)
Polysaccharides
Polycaprolactone (PCL)
PLGA
Application Segments Covered in Research Market
Drug Delivery
Orthopedics
Others

For any other requirements, please feel free to contact us and we will provide you customized report.
With tables and figures helping analyze worldwide (Post pandemic Era) Global Bioresorbable Medical Polymer market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Global Bioresorbable Medical Polymer Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate

1 Market Scope
1.1 Product Details and Introduction
1.1.1 Polylactic Acid (PLA) -Product Introduction and Major Manufacturers
1.1.2 Polyglycolic Acid (PGA) -Product Introduction and Major Manufacturers
1.1.3 Polysaccharides -Product Introduction and Major Manufacturers
1.1.4 Polycaprolactone (PCL) -Product Introduction and Major Manufacturers
1.1.5 PLGA -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

2 Global Bioresorbable Medical Polymer Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)

3 Regional Market Analysis
3.1 China Bioresorbable Medical Polymer Market
3.1.1 Top Companies leading Bioresorbable Medical Polymer Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Bioresorbable Medical Polymer Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Bioresorbable Medical Polymer Market
3.2.1 Top Companies leading Bioresorbable Medical Polymer Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Bioresorbable Medical Polymer Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Bioresorbable Medical Polymer Market
3.3.1 Top Companies leading Bioresorbable Medical Polymer Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Bioresorbable Medical Polymer Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Bioresorbable Medical Polymer Market
3.4.1 Top Companies leading Bioresorbable Medical Polymer Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Bioresorbable Medical Polymer Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Bioresorbable Medical Polymer Market
3.5.1 Top Companies leading Bioresorbable Medical Polymer Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Bioresorbable Medical Polymer Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Bioresorbable Medical Polymer Market
3.6.1 Top Companies leading Bioresorbable Medical Polymer Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Bioresorbable Medical Polymer Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Bioresorbable Medical Polymer Market
3.7.1 Top Companies leading Bioresorbable Medical Polymer Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Bioresorbable Medical Polymer Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)

4 Value Chain (Impact of COVID-19)
4.1 Bioresorbable Medical Polymer Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Bioresorbable Medical Polymer Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors

5 Regional Market Forecast (2021-2027)
5.1 Global Bioresorbable Medical Polymer Sales and Growth Rate (2021-2027)
5.2 Global Bioresorbable Medical Polymer Sales Value and Growth Rate (2021-2027)

6 Bioresorbable Medical Polymer Competitive Analysis
6.1 Evonik
6.1.1 Evonik Company Profiles
6.1.2 Evonik Product Introduction
6.1.3 Evonik Bioresorbable Medical Polymer Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Corbion
6.2.1 Corbion Company Profiles
6.2.2 Corbion Product Introduction
6.2.3 Corbion Bioresorbable Medical Polymer Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 DSM
6.3.1 DSM Company Profiles
6.3.2 DSM Product Introduction
6.3.3 DSM Bioresorbable Medical Polymer Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Mitsui Chemicals
6.4.1 Mitsui Chemicals Company Profiles
6.4.2 Mitsui Chemicals Product Introduction
6.4.3 Mitsui Chemicals Bioresorbable Medical Polymer Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 PCAS
6.5.1 PCAS Company Profiles
6.5.2 PCAS Product Introduction
6.5.3 PCAS Bioresorbable Medical Polymer Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Poly-Med
6.6.1 Poly-Med Company Profiles
6.6.2 Poly-Med Product Introduction
6.6.3 Poly-Med Bioresorbable Medical Polymer Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 KLS Martin
6.7.1 KLS Martin Company Profiles
6.7.2 KLS Martin Product Introduction
6.7.3 KLS Martin Bioresorbable Medical Polymer Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8
6.8.1 Company Profiles
6.8.2 Product Introduction
6.8.3 Bioresorbable Medical Polymer Production, Revenue (2016-2021)
6.8.4 SWOT Analysis

7 Conclusion
The (Post pandemic Era) Global Bioresorbable Medical Polymer Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

Report Objectives / Segmentation Covered :

By Companies / players:
By Regions:
By Type:
By Application:

Frequently asked questions(FAQ's):

What trends are influencing the growth of the (Post pandemic Era) Global Bioresorbable Medical Polymer Market?

New players are entering the (Post pandemic Era) Global Bioresorbable Medical Polymer Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.

What are the major applications of the (Post pandemic Era) Global Bioresorbable Medical Polymer Market?

Depending upon the type of applications, the (Post pandemic Era) Global Bioresorbable Medical Polymer Market has been segmented into and other applications.

What is the forecasted growth rate of the (Post pandemic Era) Global Bioresorbable Medical Polymer Market?

The (Post pandemic Era) Global Bioresorbable Medical Polymer Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.

Is further segmentation possible given the scope of the (Post pandemic Era) Global Bioresorbable Medical Polymer Market study?

Yes, the add-on segmentation is available in the premium customised version of the (Post pandemic Era) Global Bioresorbable Medical Polymer Market report for a more in-depth analysis. It aids in the calculation of refined and precise market values.

How is the competitive landscape for the (Post pandemic Era) Global Bioresorbable Medical Polymer Market defined?

Companies in the (Post pandemic Era) Global Bioresorbable Medical Polymer Industry are thoroughly researched and profiled in order to determine why certain trends will have a significant impact and how they will be factored into the (Post pandemic Era) Global Bioresorbable Medical Polymer Market's trajectory and future outlook.